{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:29:24Z","timestamp":1759638564562},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001288","name":"Parkinson\u2019s Disease Foundation","doi-asserted-by":"crossref","award":["IRGP 09-11"],"award-info":[{"award-number":["IRGP 09-11"]}],"id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["2006\/R1"],"award-info":[{"award-number":["2006\/R1"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT080782MF"],"award-info":[{"award-number":["WT080782MF"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK057978"],"award-info":[{"award-number":["DK057978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000863","name":"Ellison Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuroscience.2015.05.048","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T14:23:22Z","timestamp":1432909402000},"page":"576-584","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"300","author":[{"given":"R.B.","family":"Mounsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Teismann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2015.05.048_b0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","article-title":"PPAR gamma is required for placental, cardiac, and adipose tissue development","volume":"4","author":"Barak","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.012610299","article-title":"Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer","author":"Barak","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2009.06.011","article-title":"Emerging roles of peroxisome proliferator-activated receptor-beta\/delta in inflammation","volume":"124","author":"Bishop-Bailey","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","article-title":"Protective action of the peroxisome proliferator-activated receptor- gamma agonist pioglitazone in a mouse model of Parkinson\u2019s disease","volume":"82","author":"Breidert","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0035","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1124\/mol.105.017046","volume":"68","author":"Chintharlapalli","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0006-2952(01)00764-X","article-title":"Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism","volume":"62","author":"Davies","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson\u2019s disease correlates with IkappaBalpha induction and block of NFkappaB and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0055","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0060","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2011.03.062","article-title":"Mice lacking the peroxisome proliferator-activated receptor alpha gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life","volume":"186","author":"Gonzalez-Aparicio","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0080","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/jpet.106.115758","article-title":"Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo","volume":"320","author":"Iwashita","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2006.11.020","article-title":"Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production","volume":"253","author":"Jung","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.phrs.2012.02.008","article-title":"Differential susceptibility to the PPAR-gamma agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson\u2019s disease","volume":"65","author":"Laloux","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2015.04.026","article-title":"Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARgamma agonist in vitro and in MPTP-treated mice","author":"Lecca","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0110","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson\u2019s disease","volume":"99","author":"Lo","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0115","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M414390200","article-title":"Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation","volume":"280","author":"Luna-Medina","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.expneurol.2012.02.017","article-title":"Pharmacological manipulation of peroxisome proliferator-activated receptor gamma (PPARgamma) reveals a role for anti-oxidant protection in a model of Parkinson\u2019s disease","volume":"235","author":"Martin","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2013.02.058","article-title":"A peroxisome proliferator-activated receptor-delta agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"240","author":"Martin","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0135","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson\u2019s disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0140","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/en.2005-1132","article-title":"Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression","volume":"147","author":"Patsouris","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0145","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2015.05.048_b9000","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneuroim.2005.06.026","article-title":"PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis","volume":"167","author":"Raikwar","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2012.03.010","article-title":"Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression","volume":"246","author":"Sadeghian","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0155","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/aws250","article-title":"S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway","volume":"135","author":"Sathe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0160","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.85.14.5166","article-title":"Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1","volume":"85","author":"Sauer","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0165","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","article-title":"PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease","volume":"29","author":"Schintu","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0170","doi-asserted-by":"crossref","first-page":"373560","DOI":"10.1155\/2011\/373560","article-title":"Neuroprotective mechanisms of PPARdelta: modulation of oxidative stress and inflammatory processes","volume":"2011","author":"Schnegg","year":"2011","journal-title":"PPAR Res"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0175","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1073\/pnas.052707099","article-title":"The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling","volume":"99","author":"Shi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0180","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0185","doi-asserted-by":"crossref","first-page":"37770","DOI":"10.1074\/jbc.M706577200","article-title":"Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0190","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.tiv.2011.02.004","article-title":"Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte","volume":"25","author":"Wang","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0200","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.05.048_b0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cvr\/cvp151","article-title":"Regulation and pharmacology of the mitochondrial permeability transition pore","volume":"83","author":"Zorov","year":"2009","journal-title":"Cardiovasc Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221500490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221500490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T20:18:34Z","timestamp":1566764314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221500490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":42,"alternative-id":["S030645221500490X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.048","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}